Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.
Saudi Arabia is experiencing a boom in IPO activity, signaling the liberalization of its economy and a shift away from government-led privatizations that once dominated its investment market. The ...
The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
A report on energy transition investments from BloombergNEF showed that global investment in clean energy technologies hit a ...
Pimco, one of the world’s largest bond managers, owns 354 million Class A shares of Venture Global (VG), the natural-gas exporter that went ...
Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...
Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...
As most followers of the PIMCO Dynamic Income Strategy fund (PDX) know, the rapid-growth trajectory of the fund has been ...
Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...
Smithfield Foods was valued at $7.7 billion after its shares fell 3.2% on Tuesday, in a muted debut that might prompt other ...
HOUSTON (Reuters) - Federal regulators on Tuesday gave Venture Global LNG permission to introduce natural gas into the ...